Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dual phenotypes in recurrent astrocytoma, IDH-mutant; coexistence of IDH-mutant and IDH-wildtype components: a case report with genetic and epigenetic analysis.
Yamaguchi J, Ohka F, Seki M, Motomura K, Deguchi S, Shiba Y, Okumura Y, Kibe Y, Shimizu H, Maeda S, Takido Y, Yamamoto R, Nakamura A, Karube K, Saito R. Yamaguchi J, et al. Among authors: shimizu h. Acta Neuropathol Commun. 2024 Oct 26;12(1):169. doi: 10.1186/s40478-024-01879-9. Acta Neuropathol Commun. 2024. PMID: 39456052 Free article.
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia.
Ouchi F, Shingai N, Najima Y, Sadato D, Hirama C, Wakita S, Kondo K, Sadaga Y, Kato C, Sakai S, Kambara Y, Shimabukuro M, Inai K, Toya T, Shimizu H, Haraguchi K, Kobayashi T, Harada H, Okuyama Y, Yamaguchi H, Harada Y, Doki N. Ouchi F, et al. Among authors: shimizu h. Int J Hematol. 2024 Oct 26. doi: 10.1007/s12185-024-03863-4. Online ahead of print. Int J Hematol. 2024. PMID: 39455536
Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
Nakazawa N, Sano A, Kumakura Y, Yamashita T, Tanaka N, Saito K, Kimura A, Kasuga K, Nakazato K, Yoshinari D, Shimizu H, Ubukata Y, Hosaka H, Shiraishi T, Sakai M, Sohda M, Shirabe K, Saeki H. Nakazawa N, et al. Among authors: shimizu h. Oncology. 2024 Oct 24:1-17. doi: 10.1159/000541544. Online ahead of print. Oncology. 2024. PMID: 39447553
Intervention for impending pathological fractures at proximal femur is associated with lower mortality rates in patients with intermediate-to-high risk according to the Katagiri-New score.
Nishimoto T, Shimizu H, Matsuoka M, Takahashi D, Shimizu T, Iwasaki N, Kuwahara K, Soma T, Hiraga H, Iwata A. Nishimoto T, et al. Among authors: shimizu h. BMC Musculoskelet Disord. 2024 Oct 22;25(1):836. doi: 10.1186/s12891-024-07838-8. BMC Musculoskelet Disord. 2024. PMID: 39438850 Free PMC article.
6,321 results